Categories: HealthcareNews

Shockwave Medical to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

SANTA CLARA, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment cardiovascular disease, announced today that the company will be participating in the 42nd Annual J.P. Morgan Healthcare Conference, which is being held from Monday, January 8 to Thursday, January 11, 2024, in San Francisco, CA.

Shockwave management is scheduled for a live presentation on Wednesday, January 10, 2024, at 7:30 a.m. Pacific Time. Interested parties may access a live and archived webcast of the event on the “Investors” section of the company’s website at: https://ir.shockwavemedical.com.

About Shockwave Medical, Inc.
Shockwave Medical is a leader in the development and commercialization of innovative products that are transforming the treatment of cardiovascular disease. Its first-of-its-kind Intravascular Lithotripsy (IVL) technology has transformed the treatment of atherosclerotic cardiovascular disease by safely using sonic pressure waves to disrupt challenging calcified plaque, resulting in significantly improved patient outcomes. Shockwave has also recently acquired the Neovasc Reducer, which is under clinical investigation in the United States and is CE Marked in the European Union and the United Kingdom. By redistributing blood flow within the heart, the Reducer is designed to provide relief to the millions of patients worldwide suffering from refractory angina. Learn more at www.shockwavemedical.com and www.neovasc.com.

Media Contact:
Scott Shadiow
+1.317.432.9210
sshadiow@shockwavemedical.com

Investor Contact:
Debbie Kaster
investors@shockwavemedical.com

Staff

Recent Posts

Aranscia Acquires Spesana

Electronic Health Systems Pioneer Carla Balch Joins Aranscia's Executive Leadership Team HOUSTON, May 12, 2025…

18 minutes ago

New Research Shows Parents Want A Comprehensive Approach To Solving The Youth Mental Health Challenge

New Survey and Focus Group Series Underscores Parents' Worries About Youth Mental Health and Desire…

18 minutes ago

Elpis Biopharmaceuticals to Present New Data on Multi-Mechanism Armored CAR-T Therapy at PEGS Summit 2025

Proprietary cytokine-engineered CAR-T therapy shows durable anti-tumor activity and low-dose efficacy in solid tumors LEXINGTON,…

18 minutes ago

Aquiline launches Avondale Risk, a National Platform for Leading Boutique TPAs and Managed Care Providers

Intercare, InterMed, and George Hills Join the Platform ROCKLIN, Calif., May 12, 2025 /PRNewswire/ --…

18 minutes ago

EYEBUYDIRECT LAUNCHES NEW PRIDE COLLECTION AND CELEBRATES SIXTH YEAR OF PARTNERSHIP WITH THE TREVOR PROJECT

Now through June 30th, 100% of Collection Proceeds Will Benefit The Trevor Project, Continuing a…

18 minutes ago

John Morris Joins Guidehouse to Lead Global Health Segment

Renowned healthcare executive to accelerate growth in tech-driven healthcare transformation MCLEAN, Va., May 12, 2025…

18 minutes ago